Sanofi/Lexicon’s sotagliflozin filed in US and EU for type 1 diabetes
More positive results from Tecentriq, Avastin and chemo combo
The FDA has granted Breakthrough Therapy Designation to enfortumab vedotin, an antibody-drug conjugate (ADC) being developed by Seattle Genetics and Astellas.
Mitsubishi Tanabe Pharma and Hitachi have become the latest companies attempting to use artificial intelligence (AI) to more efficiently develop drugs.
Richard Staines presents a round-up of the week’s digital health news
Swiss pharma builds on existing collaboration with Science 37